Nissan Motor, Honda Motor to Consider EV Partnership — Update
By Kosaku Narioka
Nissan Motor and Honda Motor will consider an electric-vehicle partnership, seeking to catch up in an increasingly competitive market.
The two Japanese carmakers said Friday that they signed a memorandum of understanding to begin a feasibility study for a strategic partnership. The study's scope includes software and core EV parts, they said.
Japanese automakers have lagged behind their global peers in their shift to electric vehicles, trailing top players such as Tesla and China's BYD in EV sales.
As competition increased with successive vehicle-price cuts and high costs of development and production, some were forced out of the race.
Apple has ended its push to build its own electric vehicle, an effort once seen as having the potential to transform the auto industry.
Nissan has been remaking its global strategy following the restructuring of its alliance with Renault and Mitsubishi Motors announced in February last year.
Renault in January canceled the initial public offering of its electric-car unit Ampere partly due to equity-market conditions.
In October, Honda scrapped a plan to develop a series of lower-priced EVs with General Motors. However, the companies are continuing to work on a number of projects together, including an initiative to bring a driverless ride service to Japan.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
March 15, 2024 06:04 ET (10:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth